Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients (original) (raw)
References
Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO Multinational Study of vascular diseases in diabetes. Diabetologia 44:S14–S21 ArticlePubMed Google Scholar
Hammoud T, Tanguay JF, Bourassa MG (2000) Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 36:355–365 ArticlePubMedCAS Google Scholar
Gazzaruso C (2005) Erectile dysfunction and silent myocardial ischemia. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds) Harrison’s Principles of internal medicine, 16th edn. McGraw Hill Medical, New York, NY (1/13/2005 update online)
Koistinen MJ (1990) Prevalence of asymptomatic myocardial ischemia in diabetic subjects. BMJ 301:92–95 ArticlePubMedCAS Google Scholar
Lorusso R, Pentiricci S, Raddino R, Scarabelli TM, Zambelli C, Villanacci V, Burattin A, Romalelli G, Casari S, Scelsi R, Giustina A (2003) Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. Diabetes 52:2814–2820 ArticlePubMedCAS Google Scholar
Jouven X, Lemaitre RN, Rea TD, Sotoodehnia N, Empana JP, Siscovick DS (2005) Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J 26:2142–2147 ArticlePubMed Google Scholar
Huxley R, Barzi F, Woodward M (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332:73–78 ArticlePubMed Google Scholar
Smith JW, Marcus FI, Serokman R (1984) Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 54:718–721 ArticlePubMedCAS Google Scholar
Adult treatment panel III (2001) Executive summary of the third report of the national cholesterol education program (NCEP) Expert panel of detection evaluation, and treatment of high blood cholesterol in adults. JAMA 285:2486–2497 Article Google Scholar
Haffner SM, Lehto S, Ronnemaa T (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234 ArticlePubMedCAS Google Scholar
Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C (2008) Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 117:1945–1954 ArticlePubMedCAS Google Scholar
American Diabetes Association (1998) Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 21:1551–1559 Google Scholar
Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ, For the American Diabetes Association (2007) Screening for coronary artery disease in patients with diabetes. Diabetes Care 30:2729–2736 ArticlePubMed Google Scholar
Gibbsons RJ (2006) Asymptomatic patients with diabetes mellitus should not be screened for coronary artery disease. J Nucl Cardiol 13:616–620 Article Google Scholar
Wackers FJT (2006) Asymptomatic patients with diabetes mellitus should be screened for coronary artery disease. J Nucl Cardiol 13:609–615 ArticlePubMed Google Scholar
Miller TD, Redberg RF, Wackers FJT (2006) Screening asymptomatic diabetic patients for coronary artery disease. Why not? J Am Coll Cardiol 48:761–764 ArticlePubMed Google Scholar
Beller GA (2007) Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients. Is it appropriate and cost-effective? J Am Coll Cardiol 49:1918–1923 ArticlePubMed Google Scholar
Faglia E, Mantero M, Quarantiello A, Gino M, Curci V, Caminiti M, Mattioli R, Morabito A (2005) Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am Heart J 149:e1–e6 ArticlePubMed Google Scholar
Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Heller GV, Iskandrian AE, Wittlin SD, Filipchuk N, Ratner RE, Inzucchi SE, DIAD Investigators (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. The DIAD study: a randomized controlled trial. JAMA 301:1547–1555 ArticlePubMedCAS Google Scholar
Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, Valenti C, Giustina A, Garzaniti A (2008) Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with asymptomatic coronary artery disease angiographically proven. A potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol 51:2040–2044 ArticlePubMed Google Scholar
Gazzaruso C, Pujia A, Solerte SB, Amici ED, Emanuele E, Falcone C, Geroldi D, Giustina A, Garzaniti A (2006) Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients. Int J Impot Res 18:311–315 ArticlePubMedCAS Google Scholar
The Expert Committee on the diagnosis and classification of diabetes mellitus (1997) Report of the Expert Committee on the Diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197 Google Scholar
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A; ESH-ESC Task Force on the Management of Arterial Hypertension (2007) ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25(9):1751–1762
Giustina A, Perini P, Desenzani P, Bossoni S, Ianniello P, Milani M, Davì G, Romanelli G (1998) Long-term treatment with the dual antithrombotic agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients. Diabetes 47:423–430 ArticlePubMedCAS Google Scholar
Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, Fratino P (2002) Silent coronary artery disease in type 2 diabetes mellitus: the role of lipoprotein(a), homocysteine and apo(a) polymorphism. Cardiovasc Diabetol 1:5 ArticlePubMed Google Scholar
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502 PubMedCAS Google Scholar
Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A (2004) Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 110:22–26 ArticlePubMed Google Scholar
Gazzaruso C, Solerte SB, De Amici E, Mancini M, Pujia A, Fratino P, Giustina A, Garzaniti A (2006) Association of the metabolic syndrome and insulin-resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus. Am J Cardiol 97:236–239 ArticlePubMedCAS Google Scholar
Choi EK, Koo BK, Kim HS, Cho YM, Kang HJ, Cho YS, Chung WY, Chae IH, Choi DJ, Oh BH, Park YB, Choi YS (2007) Prognostic significance of asymptomatic coronary artery disease in patients with diabetes and need for early revascularization therapy. Diab Med 24:1003–1011 Google Scholar
Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M, Ocampo S, Sopko G, Ramires JA, Schneider D, Frye RL, Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group (2009) The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 120:2529–2540 ArticlePubMedCAS Google Scholar
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association, National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Statement. Circulation 112:2735–2752 ArticlePubMed Google Scholar
Martin JH, Mangiafico S, Kelly DJ (2009) Role of statins in diabetes complications. Curr Diab Rev 5:165–170 ArticleCAS Google Scholar
Albers AR, Krichavsky MZ, Balady GJ (2006) Stress testing in patients with diabetes. Diagnostic and prognostic value. Circulation 113:583–592 ArticlePubMed Google Scholar
Barthelemy O, Le Fevre C, Timsit J (2007) Silent myocardial ischemia screening in patients with diabetes mellitus. Arq Bras Endocrinol Metab 51(/2):285–293 Google Scholar
Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE, Detection of Ischemia in Asymptomatic Diabetics Investigators (2004) Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27:1954–1961 ArticlePubMed Google Scholar
Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A (2006) Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 47:65–71 ArticlePubMed Google Scholar
Poulsen MK, Henriksen JE, Vach W, Dahl J, Møller JE, Johansen A, Gerke O, Haghfelt T, Høilund-Carlsen PF, Beck-Nielsen H (2010) Identification of asymptomatic type 2 diabetes mellitus patients with a low, intermediate and high risk of ischemic heart disease: is there an algorithm? Diabetologia 53:659–667 Google Scholar
Turrini F, Messora R, Giovanardi P, Tondi S, Magnavacchi P, Cavani R, Tosoni G, Cappelli C, Pellegrini E, Romano S, Baldini A, Zennaro RG, Bondi M (2009) Screening asymptomatic patients with diabetes for unknown coronary artery disease: does it reduce risk? An open-label randomized trial comparing a strategy based on exercise testing aimed at revascularization with management based on pharmacological/behavioural treatment of traditional risk factors. DADDY-D trial (Does coronary Atherosclerosis Deserve to be Diagnosed and treated early in Diabetics?). Trial 10:119 Article Google Scholar